LA BIBLIOTHÈQUE · ÉTUDES À COMITÉ DE LECTURE

La science
de la nutrition,
à la source

Les études publiées sur les substances que nous suivons, réunies chaque jour depuis la base européenne Europe PMC. Chacune garde son titre, ses auteurs, sa revue et un lien vers l’article original. Favorable ou non à ce que nous vendons.

01Uniquement des revues à comité de lecture, référencées par PubMed
02Une collecte automatique, sans tri selon le résultat de l’étude
03Toujours le lien vers l’article original
04Le niveau de preuve affiché sur chaque étude

Les études

277 étude(s) sur 2421
Effacer la recherche et les filtres
Niveau 2 · Essai contrôléEssai randomisé contrôlé2023

Omega-3 fatty acid supplements and risk of atrial fibrillation and 'micro-atrial fibrillation': A secondary analysis from the OMEMI trial

Myhre PL, Berge T, Kalstad AA, Tveit SH, Laake K, Schmidt EB, Solheim S, Arnesen H, Seljeflot I, Tveit A · Clinical nutrition (Edinburgh, Scotland)

Background & aims : Recent randomized clinical trials have raised concerns regarding potential off target adverse effects from supplementation of n-3 polyunsaturated fatty acids (PUFA) on atrial fibrillation (AF) risk. We aimed to assess risk and potential mediators of AF and 'micro-AF' from n-3 PUFA in…

Niveau 2 · Essai contrôléEssai randomisé contrôlé2023

A randomized clinical trial of omega-3 fatty acid and vitamin D supplementation on electrocardiographic risk profiles

Tikkanen JT, Soliman EZ, Pester J, Danik JS, Gomelskya N, Copeland T, Lee IM, Buring JE, Manson JE, Cook NR, Albert CM · Scientific reports

Beneficial and adverse associations with arrhythmias have been reported for omega-3 fatty acids (omega-3 FA) and Vitamin D. The 12 lead electrocardiogram (ECG) contains quantitative measures reflecting diverse aspects of electrophysiology that might provide insights into mechanisms underlying these associations. In a…

Niveau 2 · Essai contrôléEssai randomisé contrôlé2023

Effects of Vitamin D3 and Marine Omega-3 Fatty Acids Supplementation on Indicated and Selective Prevention of Depression in Older Adults: Results From the Clinical Center Sub-Cohort of the VITamin D and OmegA-3 TriaL (VITAL)

Vyas CM, Mischoulon D, Chang G, Cook NR, Weinberg A, Copeland T, Kang JH, Bubes V, Friedenberg G, LeBoff MS, Lee IM, Buring JE, Manson JE, Reynolds CF, Okereke OI · The Journal of clinical psychiatry

Niveau 1 · SynthèseMéta-analyse2023

Does omega-3 supplementation improve the inflammatory profile of patients with heart failure? a systematic review and meta-analysis

Prokopidis K, Therdyothin A, Giannos P, Morwani-Mangnani J, Ferentinos P, Mitropoulos A, Isanejad M · Heart failure reviews

Omega-3 fatty acids are potential anti-inflammatory agents that may exert beneficial outcomes in diseases characterised by increased inflammatory profile. The purpose of this study was to comprehensively evaluate the existing research on the effectiveness of n-3 fatty acid supplementation in lowering levels of…

Niveau 2 · Essai contrôléEssai randomisé contrôlé2023

The Effect of a Fish Oil and/or Probiotic Intervention from Early Pregnancy Onwards on Colostrum Immune Mediators: A Randomized, Placebo-Controlled, Double-Blinded Clinical Trial in Overweight/Obese Mothers

Soukka J, Polari L, Kalliomäki M, Saros L, Laajala TD, Vahlberg T, Toivola DM, Laitinen K · Molecular nutrition & food research

Scope : Modifying the composition of colostrum by external factors may provide opportunities to improve the infant's health. Here, we evaluated how fish oil and/or probiotics supplementation modify concentrations of colostrum immune mediators and their associations with perinatal clinical factors on mothers with…

Niveau 3 · Étude chez l’humainÉtude observationnelle2023

Development and internal validation of a non-invasive clinical tool to predict sufficient omega-3 levels in early pregnancy

Fu JY, Wang CA, Liu G, Mead E, Phung J, Makrides M, Pennell CE · BMC pregnancy and childbirth

Background : Complications from preterm birth (PTB) are the leading cause of death and disability in those under five years. Whilst the role of omega-3 (n-3) supplementation in reducing PTB is well-established, growing evidence suggests supplementation use in those replete may increase the risk of early PTB. Aim : To…

Niveau 1 · SynthèseMéta-analyse2023

Effect of omega-3 polyunsaturated fatty acids supplementation for patients with osteoarthritis: a meta-analysis

Deng W, Yi Z, Yin E, Lu R, You H, Yuan X · Journal of orthopaedic surgery and research

Background : Omega-3 polyunsaturated fatty acids (n-3 PUFAs) confers anti-inflammatory efficacy, which has been suggested to be effective for patients with osteoarthritis (OA). However, previous studies evaluating the influence of n-3 PUFAs supplementation in patients with OA showed inconsistent results. We performed…

Niveau 2 · Essai contrôléEssai randomisé contrôlé2023

Lipid profile after omega-3 supplementation in neonates with intrauterine growth retardation: a randomized controlled trial

Elsheikh M, El Amrousy D, El-Mahdy H, Dawoud H, Harkan A, El-Barky A · Pediatric research

Background : Neonates with intrauterine growth restriction (IUGR) have a high lipid profile that predisposes them to cardiovascular disease later in life. We aimed to evaluate the effect of omega 3 supplementation on serum leptin level, lipid profile, and growth in neonates with IUGR. Methods : This clinical trial was…

Niveau 1 · SynthèseRevue systématique2023

Need for Multidimensional and Multidisciplinary Management of Depressed Preadolescents and Adolescents: A Review of Randomized Controlled Trials on Oral Supplementations (Omega-3, Fish Oil, Vitamin D3)

Pruneti C, Guidotti S · Nutrients

(1) Background: Depression is a serious health problem with a high cost for public administration. Epidemiological studies report that one in five children have a mental disorder and about 50% of mental health problems exacerbate in childhood and adolescence. Moreover, the antidepressant efficacy in children and…

Niveau 2 · Essai contrôléEssai randomisé contrôlé2023

Clinical and microbiological outcomes of subgingival instrumentation supplemented with high-dose omega-3 polyunsaturated fatty acids in periodontal treatment - a randomized clinical trial

Stańdo-Retecka M, Piatek P, Namiecinska M, Bonikowski R, Lewkowicz P, Lewkowicz N · BMC oral health

Purpose : This study aimed to evaluate the impact of dietary supplementation with omega-3 polyunsaturated fatty acids (PUFAs) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) combined with scaling and root planing (SRP) in untreated periodontitis stage III and IV. Methods : Forty patients were randomly…

Niveau 2 · Essai contrôléEssai randomisé contrôlé2023

Potential Modulation of Inflammation and Physical Function by Combined Probiotics, Omega-3 Supplementation and Vitamin D Supplementation in Overweight/Obese Patients with Chronic Low-Grade Inflammation: A Randomized, Placebo-Controlled Trial

Kopp L, Schweinlin A, Tingö L, Hutchinson AN, Feit V, Jähnichen T, Lehnert K, Vetter W, Rings A, Jensen MG, Brummer RJ, Bischoff SC · International journal of molecular sciences

Obesity is characterized by low-grade inflammation and increased gut permeability. Here, we aim to evaluate the effect of a nutritional supplement on these parameters in subjects with overweight and obesity. A double-blinded, randomized clinical trial was conducted in 76 adults with overweight or obesity (BMI 28 to…

Niveau 1 · SynthèseMéta-analyse2023

Effect of Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Outcomes in Patients with Diabetes: A Meta-analysis of Randomized Controlled Trials

Huang L, Zhang F, Xu P, Zhou Y, Liu Y, Zhang H, Tan X, Ge X, Xu Y, Guo M, Long Y · Advances in nutrition (Bethesda, Md.)

The current guidelines recommend that people consume 2 or more servings of fat-rich fish per week to obtain enough omega-3 (ω-3) polyunsaturated fatty acids to prevent cardiovascular events. However, the cardiovascular benefits of ω-3 polyunsaturated fatty acids in patients with diabetes are unclear, and related…

Lire une étude
en 5 questions

  1. 01Où est-elle publiée ?Une revue à comité de lecture, identifiable (PubMed, DOI).
  2. 02Qui a été étudié ?Des humains ? Combien ? Quel âge, quel état de santé ?
  3. 03Comment ?Randomisée, contre placebo, en double aveugle ?
  4. 04Quelle dose ?Est-ce la même dose que celle du produit qu’on vous vend ?
  5. 05Qui a financé ?Les financements et conflits d’intérêts sont déclarés en fin d’article.

Glossaire

Comité de lecture
Avant publication, l’article est examiné par des chercheurs indépendants du même domaine.
Essai randomisé
Les participants sont répartis au hasard entre les groupes, pour que les groupes soient comparables.
Double aveugle
Ni les participants ni les chercheurs ne savent qui reçoit quoi pendant l’étude.
Méta-analyse
Analyse statistique qui combine les résultats de plusieurs études sur une même question.
Revue systématique
Recensement de toutes les études publiées sur une question, selon une méthode annoncée à l’avance.
Étude observationnelle
Les chercheurs observent des personnes sans leur attribuer de traitement : elle montre un lien, pas une cause.

Contenu d’information scientifique ; il ne remplace pas l’avis d’un professionnel de santé. La présence d’une étude dans cette bibliothèque ne constitue pas une allégation sur nos produits.

Sélection automatique : articles référencés par PubMed, dont le titre nomme une substance suivie, et classés méta-analyse, revue systématique, essai ou étude observationnelle. Source des références : Europe PMC.